Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

Among patients with non-muscle-invasive bladder cancer (NMIBC), neoadjuvant treatment with mitomycin C prior to transurethral ...

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

In in vitro and in vivo preclinical studies, ficerafusp alfa + a KRAS-G12C inhibitor (G12Ci) was shown to be more effective than G12Ci alone, with G12Ci-resistant lung cancer cells remaining ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

In an exclusive excerpt from her new book, Suleika Jaouad reflects on how the devastating effects of the disease changed her ...